Skip to Content

Yakult Honsha Co Ltd ADR YKLTY

Morningstar Rating
$9.86 −0.15 (1.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

YKLTY is trading within a range we consider fairly valued.
Price
$10.04
Fair Value
$72.85
Uncertainty
High
1-Star Price
$55.24
5-Star Price
$25.41
Economic Moat
Pysrv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if YKLTY is a good fit for your portfolio.

Trading Information

Previous Close Price
$10.01
Day Range
$9.719.86
52-Week Range
$7.5126.17
Bid/Ask
$9.34 / $10.38
Market Cap
$5.98 Bil
Volume/Avg
1,363 / 5,342

Key Statistics

Price/Earnings (Normalized)
17.02
Price/Sales
1.71
Dividend Yield (Trailing)
1.74%
Dividend Yield (Forward)
1.74%
Total Yield
1.74%

Company Profile

Yakult is a pioneer in probiotics, which launched the probiotic drinks Yakult in 1935 after Minoru Shirota’s discovery of Lactobacillus casei strain Shirota, a strain of lactic acid bacteria proved to be able to live in intestines, in 1930. It operates in 40 countries across four continents selling mainly the Yakult probiotic drinks. Apart from the retail outlets, the home delivery channel, served by a team of 83,000 Yakult Ladies globally, contributes about 45% of its probiotic drink volume. Overseas markets comprise 40% of group sales and profits. Yakult has built a meaningful presence in populated emerging markets including China, Indonesia, Mexico, and Brazil. It plans to step up expansion in the U.S. It also operates a pharmaceutical business with an emphasis on oncology drugs.
Sector
Consumer Defensive
Industry
Beverages - Non-Alcoholic
Stock Style Box
Mid Growth
Total Number of Employees
29,880

Competitors

Valuation

Metric
YKLTY
02319
600887
Price/Earnings (Normalized)
17.0210.2617.97
Price/Book Value
1.521.253.41
Price/Sales
1.710.561.40
Price/Cash Flow
10.155.4610.92
Price/Earnings
YKLTY
02319
600887

Financial Strength

Metric
YKLTY
02319
600887
Quick Ratio
2.310.990.70
Current Ratio
2.691.200.99
Interest Coverage
103.374.346.62
Quick Ratio
YKLTY
02319
600887

Profitability

Metric
YKLTY
02319
600887
Return on Assets (Normalized)
9.99%5.00%6.81%
Return on Equity (Normalized)
14.84%14.46%18.67%
Return on Invested Capital (Normalized)
10.80%6.28%9.64%
Return on Assets
YKLTY
02319
600887
See how this stock stacks up to its competitors with Morningstar Investor

Beverages - Non-Alcoholic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
KO
Coca-Cola CoNjgykrkkhRpfyc$261.4 Bil
PEP
PepsiCo IncQrnqsyllBbtm$236.8 Bil
NNFSF
Nongfu Spring Co Ltd Class H Ordinary SharesNxtl$63.5 Bil
MNST
Monster Beverage CorpDqvnvlhsDqyqcr$56.1 Bil
KDP
Keurig Dr Pepper IncRfwwswwqjNftdd$42.6 Bil
CCEP
Coca-Cola Europacific Partners PLCLbzmvpsjGmcdnl$31.7 Bil
KOF
Coca-Cola Femsa SAB de CV ADRDhkmbpwqQck$18.8 Bil
COCSF
Coca-Cola Femsa SAB de CV Series LGjzgb$18.8 Bil
CELH
Celsius Holdings IncCshkkgllYsph$16.3 Bil
PRMW
Primo Water CorpTbcrkvzkLbgz$3.0 Bil

Sponsor Center